CD4 and neoplasm: Despite these limitations, it is highly promising that an anticancer response in terms of an increase in the tumor-free survival and overall survival was noted in a mouse model lacking a conventional cell-based immune response (E6 and E7 not recognized as foreign and depletion of CD4 T cells).